SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President & Chief Executive Officer, will present a company update at the C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30th at 2:30pm EST at The Palace Hotel in New York, NY.
